111 (YI) Total Non-Current Liabilities (2017 - 2025)
111 (YI) posted Total Non-Current Liabilities of $279.7 million for Q4 2025, down 11.96% sequentially from $317.7 million in Q3 2025, and down 16.22% YoY from $333.8 million in Q4 2024.
111 (YI) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends
111 has reported Total Non-Current Liabilities for 9 years, with the latest figure at $279.7 million in Q4 2025.
- Quarterly Total Non-Current Liabilities fell 16.22% year-over-year to $279.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $279.7 million (down 16.22% YoY) and the FY2025 annual result came in at $276.0 million, down 15.98% from the prior year.
- Total Non-Current Liabilities fell to $279.7 million in Q4 2025 per YI's latest filing, from $317.7 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $395.9 million in Q4 2022 and troughed at -$1.2 billion in Q2 2025.
- A 5-year average of $205.1 million and a median of $340.5 million in 2021 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities jumped 203.08% in 2022, then tumbled 443.87% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $359.0 million in 2021, then grew by 10.28% to $395.9 million in 2022, then declined by 1.5% to $390.0 million in 2023, then dropped by 14.39% to $333.8 million in 2024, then retreated by 16.22% to $279.7 million in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $279.7 million, $317.7 million, and -$1.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.04 Bn | 96.87 Bn | 3.69 Bn | 83.27 Bn |
| 2 | Cencora | 61.54 Bn | 58.73 Bn | 3.61 Bn | -2.92 Bn |
| 3 | Cardinal Health | 54.46 Bn | 49.61 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.02 Bn | 9.87 Bn | 1.10 Bn | 6.22 Bn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | 2,565.00 |
| 6 | Edap Tms | 157.24 Mn | 135.70 Mn | 7.34 Mn | 75.80 Mn |
| 7 | Accendra Health | 94.72 Mn | 87.07 Mn | 263.41 Mn | 2.45 Bn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | 251.86 Mn |
| 9 | Cosmos Health | 13.49 Mn | 11.04 Mn | 1.51 Mn | 38.31 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 279.68 Mn |
| Sep 30, 2025 | 317.66 Mn |
| Jun 30, 2025 | -1.20 Bn |
| Mar 31, 2025 | 305.59 Mn |
| Dec 31, 2024 | 333.84 Mn |
| Sep 30, 2024 | 386.72 Mn |
| Jun 30, 2024 | 348.81 Mn |
| Mar 31, 2024 | 365.51 Mn |
| Dec 31, 2023 | 389.95 Mn |
| Dec 31, 2022 | 395.88 Mn |
| Sep 30, 2022 | 333.61 Mn |
| Jun 30, 2022 | 354.87 Mn |
| Dec 31, 2021 | 358.98 Mn |
| Sep 30, 2021 | -323.66 Mn |
| Jun 30, 2021 | 347.11 Mn |
| Mar 31, 2021 | 286.09 Mn |
| Dec 31, 2020 | 255.33 Mn |
| Sep 30, 2020 | 268.22 Mn |
| Jun 30, 2020 | 182.53 Mn |
| Mar 31, 2020 | 137.51 Mn |